How to take Bosutinib

Bosutinib (Bosutinib) is an oral tyrosine kinase inhibitor commonly used to treat chronic myelogenous leukemia (CML) and other related diseases. Here are detailed instructions on how to take bosutinib:

1. Doctor’s advice and prescription

Before starting bosutinib, patients should receive evaluation and advice from their physician. The doctor will consider the patient's specific situation, including the type and stage of the disease, the patient's health, and other potential drug interactions. Patients can start using bosutinib only with a prescription from a professional doctor.

2. Dose and time

Newly diagnosed chronic phasePh+Chronic myeloid leukemia (CML): 400 mg, taken orally once a day with food.

Chronic, accelerated, or blast phasePh+Chronic myeloid leukemia (CML), resistant or intolerant to previous therapy: 500 mg, taken orally once daily with food.

For patients who do not achieve a complete hematologic, cytogenetic, or molecular response and who do not have grade 3 or higher adverse reactions, consider escalating the dose by 100 mg once daily to a maximum of 600 mg daily.

Adjust dosage based on toxicity and organ damage.

The dose of bosutinib is usually based on the patient's weight and condition. The doctor will accurately calculate the dose that is suitable for the patient and advise the patient to take it at a specific time of day. In general, bosutinib is usually a once-daily oral medication that is best taken after meals to reduce the occurrence of gastrointestinal discomfort.

3. Drug-food interactions

Bosutinib may help reduce the occurrence of gastrointestinal discomfort when taken after meals. Patients should avoid taking bosutinib with foods and supplements containing high amounts of calcium, magnesium, aluminum, and iron as these substances may affect the absorption of bosutinib. At the same time, avoid ingesting grapefruit or its products, as grapefruit may affect the metabolism of medications and increase the risk of side effects.

4. Handling of missing doses

If a patient forgets to take bosutinib within the prescribed time, he or she should decide whether to continue taking it based on the missed time. If there is a long time until the next dose, the patient can take the missed dose when they remember. However, if it is close to the next dose, patients should wait until the normal time to continue taking it and not double the dose to make up for a missed dose.

5. Management of side effects and discomfort

The use of bosutinib may be associated with some side effects, including but not limited to nausea, vomiting, diarrhea, fatigue, etc. Patients should pay close attention to these discomfort reactions during use and report to the doctor in a timely manner if necessary. Your doctor can provide advice and sometimes dosage adjustments or other measures may be needed to relieve discomfort.

6. Regular inspection and monitoring

While using bosutinib, doctors usually perform blood tests and other related tests regularly to monitor the patient's condition and the effectiveness of the drug. These examinations can help doctors adjust treatment plans in a timely manner to ensure that patients get the best treatment results.

7. The importance of continued treatment

Bosutinib is generally a long-term treatment and patients should continue using it as recommended by their doctor, even if symptoms improve. Interruption or discontinuation of bosutinib may result in recurrence or progression of the disease, so patients should strictly follow their doctor's instructions for treatment.

8. Keep in touch with your doctor

Patients should maintain close contact with their doctors while taking bosutinib. Any new symptoms, discomfort or changes in condition should be reported to the doctor promptly so that the doctor can make timely adjustments and suggestions.

In general, the method of taking bosutinib needs to be individualized and adjusted according to the patient's specific situation and the doctor's recommendations. Patients should actively cooperate with the medical team and use medications in accordance with the doctor's instructions to obtain the best therapeutic effect.

Bosutinib is not yet available in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. There are original drugs and generic drugs of bosutinib abroad. The original drugs include the Turkish original drug and the European version of the original drug. The Turkish version of the original drug costs about 2,000 to 3,000 yuan, and the European version of the original drug costs about 30,000 yuan. In addition, there are cheaper generic drugs, which cost more than one thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.